PIPELINE
Pre-clinical & clinical Development
Our pipeline advances Microneedle-enabled therapeutics from preclinical development toward first-in-human studies, with a focus on controlled delivery, translational development and program de-risking.
Lead Development Programs
Advancing our lead investigational microneedle programs toward clinical evaluation.
EPQ-MAP-01
Neurological disorders
EPQ-MAP-02
Cancer-related pain
Beyond Our Lead Programs
Exploring additional applications of our microneedle technology platform.
Hormonal Therapies
Exploring potential applications in hormonal medicine
Complex Small Molecules
Exploring formulation opportunities for complex pharmaceutical compounds
Veterinary Applications
Exploring potential applications in animal health
Your Molecule. Our Platform.
We welcome conversations with pharmaceutical and research partners interested in exploring microneedle-based approaches for their development programs.
All programs are investigational and subject to ongoing research, technical feasibility and applicable regulatory requirements. Development stages and timelines are indicative. Progress bars illustrate relative stage positioning, rather than validated percentages of completion.